Sleep Research Group, Charles Perkins Centre, University of Sydney, Camperdown, Sydney, New South Wales, Australia; Department of Respiratory & Sleep Medicine, Royal North Shore Hospital, 8A, Acute Services Building, Reserve Road, St Leonards, Sydney, New South Wales 2065, Australia.
Department of Orthodontics and Paediatric Dentistry, University of Sydney, Surry Hills, New South Wales, Australia; Department of Orthodontics, Sydney Dental Hospital, 2 Chalmers Street, Surry Hills, New South Wales 2010, Australia.
Sleep Med Clin. 2021 Mar;16(1):145-154. doi: 10.1016/j.jsmc.2020.10.004. Epub 2020 Dec 7.
Long-term effective therapy is essential for obstructive sleep apnea (OSA) control and preventing comorbidity. OSA patients are often reported to be more receptive to oral appliance therapy over positive airway pressure (PAP). Oral appliance usage can now be objectively recorded by temperature microsensors. Studies using commercially available microsensor chips have reported data out to 1 year, with high rates of adherence (>80%), albeit in small samples. There is opportunity to further use this technology to understand individual adherence factors and patterns and in obtaining objective measures of treatment effectiveness, particularly for longer-term health outcomes and allowing comparison to PAP.
长期有效的治疗对于控制阻塞性睡眠呼吸暂停（OSA）和预防合并症至关重要。据报道，OSA 患者通常更愿意接受口腔矫治器治疗而非气道正压通气（PAP）。现在可以通过温度微传感器来客观地记录口腔矫治器的使用情况。使用市售微传感器芯片的研究报告的数据最长可达 1 年，尽管样本量较小，但使用率很高（>80%）。有机会进一步利用这项技术来了解个人依从因素和模式，并获得治疗效果的客观指标，特别是对于长期健康结果，并允许与 PAP 进行比较。
